Search Results Search Sort by RelevanceMost Recent State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407. Policy Forum Sep 2016 Overcoming Historical Separation between Oral and General Health Care: Interprofessional Collaboration for Promoting Health Equity Lisa Simon, DMD Health equity requires physician-dentist collaboration. What are next steps for integrating oral and general health care? AMA J Ethics. 2016;18(9):941-949. doi: 10.1001/journalofethics.2016.18.9.pfor1-1609. In the Literature Jun 2007 Cosmetic Psychopharmacology and the Goals of Medicine Erica K. Rangel A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology. Virtual Mentor. 2007;9(6):428-432. doi: 10.1001/virtualmentor.2007.9.6.jdsc1-0706.
State of the Art and Science Dec 2016 Locating Risk in the Adolescent Brain: Ethical Challenges in the Use of Biomarkers for Adolescent Health and Social Policy Suparna Choudhury, PhD and Sheehan Moore Neurobiological markers raise complex questions about what it means to be “at risk.” AMA J Ethics. 2016;18(12):1199-1206. doi: 10.1001/journalofethics.2016.18.12.stas1-1612.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 1 Stephen L. Brotherton, MD Virtual Mentor. 2004;6(7):298-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 2 Norman C. Fost, MD, MPH Virtual Mentor. 2004;6(7):300-301. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Case and Commentary Jul 2004 Performance-Enhancing Drugs in Sports, Commentary 3 Gary A. Green, MD Virtual Mentor. 2004;6(7):301-303. doi: 10.1001/virtualmentor.2004.6.7.ccas2-0407.
Policy Forum Sep 2016 Overcoming Historical Separation between Oral and General Health Care: Interprofessional Collaboration for Promoting Health Equity Lisa Simon, DMD Health equity requires physician-dentist collaboration. What are next steps for integrating oral and general health care? AMA J Ethics. 2016;18(9):941-949. doi: 10.1001/journalofethics.2016.18.9.pfor1-1609.
In the Literature Jun 2007 Cosmetic Psychopharmacology and the Goals of Medicine Erica K. Rangel A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology. Virtual Mentor. 2007;9(6):428-432. doi: 10.1001/virtualmentor.2007.9.6.jdsc1-0706.